Orchid Pharma Market Cap ($658.74M USD)
Orchid Pharma Market Cap ($658.74M USD). As of Oct. 5, 2026, Orchid Pharma (ORCHPHARMA) market capitalisation is ₹5928.63 Cr ($658.74M), with 6.14 Cr shares outstanding at a current price of ₹965.90 on NSE, ranking 754 out of 5368 companies by market cap in our screener. Orchid Pharma operates in the Healthcare sector and is classified as a Mid Cap stock. Compare with ORCHPHARMA fair price to assess whether the stock is under or overvalued.
Market Cap History of Orchid Pharma (Last 10 Years)
ORCHPHARMA market capitalisation from year-end NSE closing prices over the last 10 years. For live price, earnings and the complete company profile, see Orchid Pharma stock price NSE.
End of Year Market Cap History — Orchid Pharma
ORCHPHARMA year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Examine ORCHPHARMA quarterly results for recent quarterly revenue, profit and EPS trends.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹5928.63 Cr
$658.74M USD
|
₹965.90 | NSE | +27.27% |
| 2025 |
₹4658.38 Cr
$517.60M USD
|
₹758.95 | NSE | -58.00% |
| 2024 |
₹11091.55 Cr
$1.23B USD
|
₹1807.05 | NSE | +153.62% |
| 2023 |
₹4373.28 Cr
$485.92M USD
|
₹712.50 | NSE | +95.71% |
| 2022 |
₹2234.51 Cr
$248.28M USD
|
₹364.05 | NSE | -7.81% |
| 2021 |
₹2423.87 Cr
$269.32M USD
|
₹394.90 | NSE | +220.41% |
| 2020 |
₹756.50 Cr
$84.06M USD
|
₹123.25 | NSE | +2247.62% |
| 2019 |
₹32.22 Cr
$3.58M USD
|
₹5.25 | BSE | +10.99% |
| 2018 |
₹29.03 Cr
$3.23M USD
|
₹4.73 | BSE | -74.71% |
| 2017 |
₹114.78 Cr
$12.75M USD
|
₹18.70 | BSE | -31.00% |
| 2016 |
₹166.34 Cr
$18.48M USD
|
₹27.10 | BSE | -58.24% |
| 2015 |
₹398.35 Cr
$44.26M USD
|
₹64.90 | BSE | -0.08% |
| 2014 |
₹398.66 Cr
$44.30M USD
|
₹64.95 | BSE | -1.81% |
| 2013 |
₹406.02 Cr
$45.11M USD
|
₹66.15 | BSE | -34.28% |
| 2012 |
₹617.78 Cr
$68.64M USD
|
₹100.65 | BSE | -20.65% |
| 2011 |
₹778.60 Cr
$86.51M USD
|
₹126.85 | BSE | -58.26% |
| 2010 |
₹1865.26 Cr
$207.25M USD
|
₹303.89 | BSE | +65.11% |
| 2009 |
₹1129.69 Cr
$125.52M USD
|
₹184.05 | BSE | +100.05% |
| 2008 |
₹564.69 Cr
$62.74M USD
|
₹92.00 | BSE | - |